Results 201 to 210 of about 1,616,748 (350)

Mycoplasma pneumoniae‐Induced Rash and Mucositis: Clinicopathologic Characterization of 11 Cases

open access: yesJournal of Cutaneous Pathology, EarlyView.
ABSTRACT Background Mycoplasma pneumoniae‐induced rash and mucositis (MIRM) is a mucocutaneous eruption affecting children and young adults with respiratory tract or clinically occult infection by M. pneumoniae. Mucosal involvement is often robust and may raise concern for Stevens–Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).
Margaret Lang Houser   +5 more
wiley   +1 more source

Constitutional symptoms and response to Penicillin G in erysipelas and cellulitis – a monocentric, retrospective, explorative study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Erysipelas, caused by streptococci, should be treated with penicillin, while uncomplicated cellulitis (phlegmon), often caused by Staphylococcus aureus, requires penicillinase‐resistant beta‐lactam antibiotics, which have a higher risk of adverse effects. Distinguishing between these infections is important.
Helena Schieffers, Cord Sunderkötter
wiley   +1 more source

Elucidation of Bacterial Pneumonia-Causing Pathogens in Patients with Respiratory Viral Infection [PDF]

open access: diamond, 2017
Hwa Sik Jung   +11 more
openalex   +1 more source

Public health reforms and the mortality decline in nineteenth‐century Italy

open access: yesThe Economic History Review, EarlyView.
Abstract This study examines the impact of Italy's 1887–8 health reforms on mortality, contributing to the historical debate on the state's role in Europe's health transition. Leveraging event‐study‐style difference‐in‐differences approach, we assess the effectiveness of the Crispi–Pagliani reforms, which strengthened public health governance and ...
Francesco Maria Salvatore Fiore Melacrinis   +1 more
wiley   +1 more source

The value of signs and symptoms in differentiating between bacterial, viral and mixed aetiology in patients with community-acquired pneumonia

open access: green, 2013
Elisabeth G. W. Huijskens   +5 more
openalex   +2 more sources

Safety and Efficacy of Damoctocog Alfa Pegol in Previously Treated Children Aged 7 to < 12 Years With Severe Haemophilia A in the Phase 3, Open Label Alfa‐PROTECT Main Study

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Background In the earlier PROTECT VIII Kids study (NCT01775618), damoctocog alfa pegol was efficacious for prevention and treatment of bleeds in children aged < 12 years with severe haemophilia A. Objective Assess the safety of damoctocog alfa pegol, including hypersensitivity and loss of efficacy (LoE) due to an immune response to ...
Margareth C. Ozelo   +13 more
wiley   +1 more source

Genetic Sequencing of a Bacterial Pneumonia Vaccine Produced in 1916. [PDF]

open access: yesVaccines (Basel)
Xiao Y   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy